Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
6.92
+6.73 (3,571.09%)
Apr 15, 2025, 4:00 PM EDT - Market closed
Scilex Holding Company Employees
Scilex Holding Company had 115 employees as of December 31, 2024. The number of employees increased by 10 or 9.52% compared to the previous year.
Employees
115
Change (1Y)
10
Growth (1Y)
9.52%
Revenue / Employee
$492,087
Profits / Employee
-$633,104
Market Cap
36.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 115 | 10 | 9.52% |
| Dec 31, 2023 | 105 | 15 | 16.67% |
| Dec 31, 2022 | 90 | 14 | 18.42% |
| Dec 31, 2021 | 76 | - | - |
SCLX News
- 15 hours ago - Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada's Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®'s Acute Treatment of Migraine With or Without Aura in Canada - GlobeNewsWire
- 4 days ago - Scilex Holding Company Announces 1-for-35 Reverse Stock Split - GlobeNewsWire
- 20 days ago - Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva - GlobeNewsWire
- 5 weeks ago - Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025 - GlobeNewsWire
- 2 months ago - Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025 - GlobeNewsWire
- 3 months ago - Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1) - GlobeNewsWire
- 3 months ago - Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025 - GlobeNewsWire
- 3 months ago - Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC - GlobeNewsWire